Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy.
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy. chiricozziandrea@gmail.com.|Skin Biology Laboratory, University of Rome Tor Vergata, Rome, Italy. chiricozziandrea@gmail.com.
A
A
Chiricozzi
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.|Skin Biology Laboratory, University of Rome Tor Vergata, Rome, Italy.
M V
MV
Cannizzaro
Ophthalmology Department, University of Rome Tor Vergata, Rome, Italy.
G A
GA
Salandri
Skin Biology Laboratory, University of Rome Tor Vergata, Rome, Italy.
B
B
Marinari
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
R
R
Pitocco
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
A
A
Dattola
Ophthalmology Department, University of Rome Tor Vergata, Rome, Italy.
F
F
Regine
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
R
R
Saraceno
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
L
L
Bianchi
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy.
S
S
Chimenti
Dermatology Unit, NESMOS Department, Sapienza University of Rome, Rome, Italy.
A
A
Costanzo
D000068879:Adalimumab / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D006801:Humans; D020381:Interleukin-17 / Q000378:metabolism*; D011565:Psoriasis / Q000188:drug therapy* / Q000378:metabolism; D012720:Severity of Illness Index; D013666:Tears / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D020381:Interleukin-17; D000068879:Adalimumab